MIT develops scalable 3D-printed nozzles for drug-delivery particles, addressing production inefficiencies in pharmaceutical manufacturing
Original framing: “3D-printed nozzle array could streamline production of drug-delivery microparticles” — Phys.org
The triaxial electrospray emitters represent a scientifically validated method for producing uniform microparticles. Their 3D-printed design allows for customization and scalability, which is supported by peer-reviewed research and experimental validation.
The development of 3D-printed triaxial electrospray emitters represents a convergence of technological innovation, global health equity, and cultural inclusivity.
By integrating indigenous knowledge with modern engineering, this technology has the potential to decentralize pharmaceutical production and empower marginalized communities. The historical parallels with open-source software suggest that democratizing access to this innovation could disrupt entrenched corporate monopolies and create more resilient health systems. However, this potential can only be realized through cross-cultural collaboration, policy reform, and a commitment to participatory design. The trickster element lies in how a small engineering breakthrough could catalyze a broader transformation in global health infrastructure.